期刊文献+

老年心房颤动抗栓治疗 被引量:2

Antithrombotic therapy for elderly patients with atrial fibrillation
暂未订购
导出
摘要 老年患者心房颤动(简称房颤)患病率高,房颤相关卒中致死、致残率高。临床实践中,老年房颤患者抗凝应用普遍不足,但年龄本身并不是抗凝禁忌,对老年房颤患者应兼顾血栓栓塞及出血风险,合理选择抗栓药物。 The prevalence of atrial fibrillation among elderly stroke patients is high. Atrial fibrillation-related strokes are associated with higher mortality and greater disability. Anticoagulation is largely underused in elderly patients with atrial fibrillation in Clinical practice. However, increasing age should not be a contraindication to anticoagulation. An appropriate anticoagulant should be selected by taking into account the individual patient's risk of thromboembolism and bleeding in elderly patients with atrial fibrillation.
作者 吴书林 黄俊
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2016年第4期265-267,共3页 Chinese Journal of Practical Internal Medicine
关键词 老年 心房颤动 抗栓治疗 elderly atrial fibrillation antithrombotic therapy
  • 相关文献

参考文献12

  • 1Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study[J].JAMA, 2001, 285(18): 2370-2375.
  • 2Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of China's Mainland[J]. J Epidemiol, 2008, 18(5): 209-216.
  • 3Carom AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the EuroFean Heart Rhythm Association[J]. Eur Heart J, 2012, 33(21 ): 2719-2747.
  • 4January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2014, 64(21 ): e 1-76.
  • 5Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial[J]. Lancet, 2007, 370(9586): 493-503.
  • 6Lip GY, Lane DA. Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly[J]. Cifc J, 2013,77(6): 1380-1388.
  • 7Siu CW, Tse HF. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2014, 7 ( 2): 300-306.
  • 8Zhang LF, Yang J, Hong Z, et al. Proportion of different subtypes of stroke in China[J]. Stroke, 2003, 34(9): 2091-2096.
  • 9Shen AY YaoJF, Brar SS, et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation [J]. J Am Coil Cardiol, 2007, 50(4): 309-315.
  • 10Wu J, Wang J, Jiang S, et al. The efficacy and safety of low intensity warfarin therapy in Chinese elderly atrial fibrillation patients with high CHADS2 risk score[J]. IntJ Cardiol, 2013, 167 (6): 3067-3068.

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部